-0.002 (-6.667%)
ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/A
Telephone
61.2.9874.8761
Address
Suite 301 55 Lime Street Sydney, New South Wales (NSW) 2000
Description
CardieX Ltd. engages in the provision of designing, manufacturing, and marketing medical devices used in cardiovascular health management. It operates through the following geographical segments: Americas, Europe, and Asia Pacific. The Americas segment includes pharmaceutical trials business. The Europe segment focuses on the Middle East and Africa. The Asia Pacific segment is involved in the operations of Asia, Australia, and New Zealand. The company was founded by Ross Harricks, Niall Charles Edgar Cairns, Craig R. Cooper, and Michael Francis O'Rourke in 1994 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.03 - 0.17
Trade Value (12mth)
AU$5,516.00
1 week
-6.67%
1 month
-17.65%
YTD
-71.07%
1 year
-52.27%
All time high
7.64
EPS 3 yr Growth
-62.70%
EBITDA Margin
-408.50%
Operating Cashflow
-$11m
Free Cash Flow Return
-201.20%
ROIC
-244.20%
Interest Coverage
-21.90
Quick Ratio
1.20
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
27-Aug-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
29 August 25 |
Unmarketable Parcels of Shares (Buy-Back)
×
Unmarketable Parcels of Shares (Buy-Back) |
|
29 August 25 |
Appendix 4E
×
Appendix 4E |
|
29 August 25 |
FY25 Preliminary Results Summary and Company Update
×
FY25 Preliminary Results Summary and Company Update |
|
15 August 25 |
Notice of Extraordinary General Meeting/Proxy Form
×
Notice of Extraordinary General Meeting/Proxy Form |
|
15 August 25 |
Proposed issue of securities - CDX
×
Proposed issue of securities - CDX |
|
31 July 25 |
June Quarterly Appendix 4C
×
June Quarterly Appendix 4C |
|
31 July 25 |
June Quarterly Activities Report
×
June Quarterly Activities Report |
|
15 July 25 |
Notification regarding unquoted securities - CDX
×
Notification regarding unquoted securities - CDX |
|
15 July 25 |
Update - Notification regarding unquoted securities - CDX
×
Update - Notification regarding unquoted securities - CDX |
|
02 July 25 |
Appendix 3Y x3
×
Appendix 3Y x3 |
|
27 June 25 |
Application for quotation of securities - CDX
×
Application for quotation of securities - CDX |
|
24 June 25 |
Results of Entitlement Offer
×
Results of Entitlement Offer |
|
18 June 25 |
Entitlement Offer Closing & Deadline for Applications
×
Entitlement Offer Closing & Deadline for Applications |
|
13 June 25 |
Cardiex Investor Webinar Presentation
×
Cardiex Investor Webinar Presentation |
|
10 June 25 |
Cardiex Investor Webinar
×
Cardiex Investor Webinar |
|
06 June 25 |
Offer Booklet - Non-Renounceable Entitlement Offer
×
Offer Booklet - Non-Renounceable Entitlement Offer |
|
06 June 25 |
Despatch of Entitlement Offer Booklet
×
Despatch of Entitlement Offer Booklet |
|
06 June 25 |
Entitlement Offer Letter to Ineligible Shareholders
×
Entitlement Offer Letter to Ineligible Shareholders |
|
05 June 25 |
Application for quotation of securities - CDX
×
Application for quotation of securities - CDX |
|
05 June 25 |
Cleansing Notice
×
Cleansing Notice |
|
04 June 25 |
Cardiex Successfully Completes Institutional Placement
×
Cardiex Successfully Completes Institutional Placement |
|
02 June 25 |
Cardiex Receives TGA Approval for CONNEQT Pulse Device
×
Cardiex Receives TGA Approval for CONNEQT Pulse Device |
|
30 May 25 |
Cardiex Completes Placement & Launches Entitlement Offer
×
Cardiex Completes Placement & Launches Entitlement Offer |
|
30 May 25 |
Proposed issue of securities - CDX
×
Proposed issue of securities - CDX |
|
30 May 25 |
Cleansing Notice
×
Cleansing Notice |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
